Sickle Cell Disease is rightly considered to be a horrible condition. It is thought that about 15,000 people have the condition, in England alone, affecting people mainly of Black African and Caribbean heritage. It can cause intense, recurring pain, and it can be life-changing, and even life-threatening.
The NHS has announced that a new, "groundbreaking", individualised 'gene editing' therapy will be offered to patients in England on the National Health Service (NHS). Good news, then?
The main problem is that the treatment is going to cost the already over-stretched, almost bankrupted NHS £1.65 million per patient. It is expected that 50 people per year will be offered the treatment - total expenditure of an astonishing £82.5 million per annum.
If the treatment works, this may represent excellent value - at least for 50 people every year. But the NHS spending this amount of money represents what is known, in economic jargon, as "an opportunity cost", that is, the opportunity to spend this money on other things.
Other things, for example, like spending money on the treatment of the remaining 14,950 people who currently suffer with sickle cell disease!
Conventional medicine always does this. It comes up with new, 'groundbreaking' treatments that are so expensive they are either not used, or used only by people wealthy enough to pay for their own treatment, or used with a tiny number of people at public expense.
So I have an alternative suggestion!
Earmark this £82.5 million for sickle cell disease. Divide the money between the 15,000 patients who suffer from the disease, and allow each patient to spend their £5,500 on homeopathic treatment!
Homeopathy has been treating Sickle Cell Disease for many, many years; often with complete success. Do a web search - "homeopathy, sickle cell", and see for yourself. Even if each consultation with a homeopath costs £100 per month (with remedies), not one of these 15,000 patients will have to spend more that £1,200 on their treatment.
The remaining £4,300 could then be spent by the 15,000 sickle cell patients on celebrating their freedom from the disease.
It is time for some new, "groundbreaking" thinking about how the NHS spends public money - on treatment that actually works
